BRAF in Melanoma‚ÄĒCustomized Content by Region

New!

We are pleased to announce the availability of BRAF Q&A content customized for regional audiences!

Supported by an educational grant from Novartis Pharmaceuticals, these resources were developed to get region-centric, translated resources into the hands of more clinicians to share with patients. In addition, the individual pages will also be promoted to patients within those regions with the support of advocacy groups.

Materials are available for the following regions: